Mortality of Acute Infective Endocarditis
The in-hospital mortality of acute infective endocarditis ranges from 15-26%, with critically ill patients experiencing substantially higher rates of 29-84%, and prosthetic valve endocarditis carrying a particularly grave prognosis of 20-40%. 1, 2
Overall Mortality Rates
The mortality burden of infective endocarditis remains stubbornly high despite modern therapeutic advances:
- In-hospital mortality: 15-26% across most contemporary series 1, 2, 3, 4
- 6-month mortality: 27% 5
- 1-year mortality: 31% 5
- 5-year mortality: 44% 5
These figures have not improved over time despite advances in diagnostics, antibiotics, and surgical techniques 2, 5. The 2015 ESC Guidelines emphasize that outcomes have remained static even as surgical intervention rates have increased to approximately 50% of cases 2.
High-Risk Subgroups with Elevated Mortality
Prosthetic Valve Endocarditis (PVE)
PVE carries a very high in-hospital mortality of 20-40% 1. The most powerful predictors of death in PVE include:
- Complicated PVE with abscess formation
- Staphylococcal infection (particularly S. aureus)
- Early PVE (within 1 year of valve surgery)
- Heart failure
- Stroke
- Healthcare-associated infections
Critically Ill Patients
Patients requiring ICU admission face mortality rates of 29-84% 1. Emergency or salvage cardiac surgery carries the highest mortality in registry data, and patients with Sequential Organ Failure Assessment (SOFA) scores >15 on the day of surgery have extremely poor outcomes 1.
Right-Sided Endocarditis
In contrast, right-sided IE has a substantially lower in-hospital mortality of approximately 7% 1, making it the most favorable subtype prognostically.
Key Mortality Predictors
Based on multivariate analysis from recent studies, the strongest independent predictors of death include:
Short-term mortality predictors:
- Periannular abscess formation (OR 4.95) 6
- Poor cardiac function (NYHA class III-IV) 6
- Acute kidney injury 7, 6
- Sepsis 7
Long-term mortality predictors:
- Advanced age (HR 1.37 per decade) 5
- Cerebral infarction/stroke (HR 1.94) 6, 5
- Impaired renal function (HR 1.03) 5
- Reduced ejection fraction at admission (HR 1.38) 5
- Methicillin-resistant S. aureus infection (HR 2.56 compared to Streptococcal infection) 5
Pathogen-Specific Mortality
The causative organism significantly impacts prognosis:
- Staphylococcal IE (particularly MRSA): Highest mortality, especially in PVE 1, 5
- Fungal IE: Very high mortality, with vegetation length >20mm predicting death 1
- Streptococcal IE: Generally better prognosis, particularly non-group D streptococci 8
- Gram-positive bacteria (other than streptococci/staphylococci): Up to 62% mortality 8
Impact of Surgical Intervention
Surgical treatment is associated with improved outcomes when appropriately timed:
- Surgery reduces short-term poor outcomes (OR 0.21) 6
- Surgery improves long-term survival (HR 0.20) 6
- However, emergency/salvage surgery carries the highest mortality risk 1
The decision for surgery must balance the high operative risk against the natural history of untreated complicated IE, requiring multidisciplinary team evaluation 1, 2.
Critical Pitfalls
Common errors that worsen mortality:
- Starting antibiotics before obtaining adequate blood cultures (at least 3 sets) 3
- Failing to use bactericidal antibiotics
- Stopping therapy prematurely
- Delaying indicated cardiac surgery 3
- Inadequate initial antibiotic therapy leading to recurrence 1
The mortality of IE has not declined despite modern advances 2, 5, emphasizing the need for aggressive early management, prompt recognition of surgical indications, and coordinated multidisciplinary care involving cardiologists, infectious disease specialists, microbiologists, and cardiac surgeons 2, 9.